id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-E-0151-0001,FDA,FDA-2001-E-0151,Determination of Regulatory Review Period for Purposes of Patent Extension; Trileptal,Notice,General Notice,2001-09-24T04:00:00Z,2001,9,2001-09-24T04:00:00Z,2001-11-24T04:59:59Z,2025-09-15T16:10:58Z,,0,0,09000064804ddd1d